CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Almirall SA Company Snapshot
Almirall SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Almirall SA with three other pharmaceutical manufacturers in Europe: Guerbet SA of France (2016 sales of 775.77 million Euro [US$893.74 million] of which 48% was X-rays), Alkermes Plc of Ireland (675.61 million Euro [US$778.35 million] of which 100% was Pharmaceuticals), and Virbac which is based in France (871.83 million Euro [US$1.00 billion] of which 58% was Companion Animals).

Sales Analysis. Almirall SA reported sales of 764.36 million Euro (US$880.60 million) for the year ending December of 2016. This represents an increase of 11.6% versus 2015, when the company's sales were 684.99 million Euro. Despite this increase, sales are still below the level achieved in 2014, when Almirall SA reported sales of 786.40 million Euro. The sales level in 2016 was fairly close to the level five years ago: in 2011, Almirall SA had sales of 768.42 million Euro. Sales of Licenses saw an increase that was more than double the company's growth rate: sales were up 126.5% in 2016, from 40.13 million Euro to 90.89 million Euro. Almirall SA also saw significant increases in sales in Dermatology (up 35.6% to 203.39 million Euro) . Not all segments of Almirall SA experienced an increase in sales in 2016: sales of Own Network (Spain) fell 5.1% to 448.12 million Euro. Almirall SA also experienced decreases in sales in Corporate (down 3.7% to 21.96 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Almirall SA
  Stock Performance Chart for Almirall SA
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 8.70
(Figures in Euro)
1 Week -5.5%   13 Weeks -41.5%  
4 Weeks -44.3%   52 Weeks -35.3%  
 
Almirall SA Key Data:
  Ticker: ALM Country: Spain
  Exchanges: BCN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 764,361,000
(Year Ending Jan 2017).
Employees: 1,923
  Currency: Euro Market Cap: 1,504,674,744
  Fiscal Yr Ends: December Shares Outstanding: 172,951,120
  Share Type: Accion Closely Held Shares: 115,697,775
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.